Hepatic Lipid Metabolism-Alcohol Use Disorder | MicrobiomeTrials← Back to trialsNCT07191561
Hepatic Lipid Metabolism-Alcohol Use Disorder
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2027-11-30
Enrollment target: 25 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Alcohol Use Disorder
Background:
Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD trea…
Baltimore, United StatesEst. completion Mar 1, 2027
PTSDAlcohol Use Disorder
The primary objective of the proposed Stage II study is to examine the efficacy of oxytocin (OT) as compared to placebo …
Charleston, United StatesCompleted Apr 13, 2026
Completed
Substance-Related DisordersAlcohol-Related DisordersAlcohol Use Disorder (AUD)
The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activi…
Gijón, SpainCompleted Jul 1, 2025